Published in Biol Trace Elem Res on May 11, 2013
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26
Mitochondria as the central control point of apoptosis. Trends Cell Biol (2000) 5.91
Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity. Mol Cell (2006) 4.26
Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) (2007) 3.17
Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature (2011) 2.82
Regulatory T cells in the periphery. Immunol Rev (2006) 1.94
The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth (2003) 1.75
CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol (1999) 1.58
Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals (2002) 1.55
Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun (2004) 1.52
Second messenger function of nicotinic acid adenine dinucleotide phosphate revealed by an improved enzymatic cycling assay. J Biol Chem (2006) 1.30
Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc Natl Acad Sci U S A (2012) 1.26
Role of magnesium in carbon partitioning and alleviating photooxidative damage. Physiol Plant (2008) 1.10
Serum magnesium and atherogenic lipid fractions in type II diabetic patients of Lahore, Pakistan. Biol Trace Elem Res (2012) 1.07
Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf) (2011) 1.04
Mysteries of magnesium homeostasis. Circ Res (2000) 1.04
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) (2004) 1.01
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf) (2006) 0.99
Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. J Immunol (2011) 0.99
A variant of the Il2ra / Cd25 gene predisposing to graves' disease is associated with increased levels of soluble interleukin-2 receptor. Scand J Immunol (2011) 0.96
Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances. Magnes Res (2000) 0.94
Cell signaling, beyond cytosolic calcium in eukaryotes. J Inorg Biochem (2008) 0.91
The treatment of Graves' disease in children. J Pediatr Endocrinol Metab (2006) 0.91
B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand J Immunol (2012) 0.91
Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. J Endocrinol (2007) 0.90
Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy. Endokrynol Pol (2012) 0.88
Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69. Clin Immunol Immunopathol (1998) 0.85
The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res (2012) 0.85
Gedunin, a natural tetranortriterpenoid, modulates T lymphocyte responses and ameliorates allergic inflammation. Int Immunopharmacol (2012) 0.84
Extrathyroidal actions of antithyroid thionamides. Toxicol Lett (2002) 0.83
Higher dose of methimazole causes frequent adverse effects in the management of Graves' disease in children and adolescents. J Pediatr Endocrinol Metab (2012) 0.82
Rituximab in the treatment of thyroid eye disease: science fiction? Orbit (2009) 0.82
Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res (2013) 0.81
Magnesium metabolism in hyperthyroidism. Endocr J (1996) 0.81
The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Autoimmunity (2007) 0.81
Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature. J Pediatr Endocrinol Metab (2005) 0.80
Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients. J Leukoc Biol (2012) 0.80
Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease. J Clin Endocrinol Metab (1996) 0.79
Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol (2006) 0.79
Fas-induced B cell apoptosis requires an increase in free cytosolic magnesium as an early event. J Biol Chem (1999) 0.79
Immunology: Magnesium in a signalling role. Nature (2011) 0.79
Magnesium lithospermate B mediates anti-inflammation targeting activator protein-1 and nuclear factor-kappa B signaling pathways in human peripheral T lymphocytes. Int Immunopharmacol (2012) 0.79
Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation. Immunobiology (2013) 0.78
Downregulation of CD94/NKG2A inhibitory receptor on decreased γδ T cells in patients with systemic lupus erythematosus. Scand J Immunol (2012) 0.78
Prevalence, presentation and clinical evolution of Graves' disease in children and adolescents with type 1 diabetes mellitus. Horm Res Paediatr (2011) 0.78
Dense mapping of IL2RA shows no association with Graves' disease in Chinese Han population. Clin Endocrinol (Oxf) (2013) 0.77
Excessive decrease in serum magnesium after total thyroidectomy for Graves' disease is related to development of permanent hypocalcemia. World J Surg (2013) 0.77
Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB. Int J Oncol (2013) 0.77
Intrathyroidal T cell accumulation in Graves' disease: delineation of mechanisms based on in situ T cell receptor analysis. J Clin Endocrinol Metab (1996) 0.76
Alteration of plasma trace elements in patients undergoing open heart surgery. Biol Trace Elem Res (2012) 0.76
Atrial natriuretic peptide and thyroid hormones' relation to plasma and heart calcium and magnesium concentrations of Wistar rats exposed to cold and hot ambients. Biol Trace Elem Res (2000) 0.76
Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy. Horm Metab Res (2012) 0.76
CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation. Biochim Biophys Acta (2013) 0.76
Effects of serum calcium and magnesium on heart rate variability in adult women. Biol Trace Elem Res (2012) 0.76
Antithyroid drug-induced immunomodulation in Graves' disease patients. Acta Med Croatica (2002) 0.76
The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol (2012) 1.24
Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep (2008) 1.10
The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol (2002) 0.91
Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas. Oncol Rep (2011) 0.89
Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome. Oncol Rep (2008) 0.89
Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome. Oncol Rep (2010) 0.89
Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia. Haematologica (2002) 0.89
T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis. Leuk Res (2002) 0.89
Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Int J Oncol (2006) 0.88
Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult Scler (2010) 0.88
CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer. Oncol Rep (2008) 0.85
Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Derm Venereol (2003) 0.81
Generation of dendritic cells from human peripheral blood monocytes--comparison of different culture media. Folia Histochem Cytobiol (2005) 0.80
Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflamm (2013) 0.80
Apoptosis signaling is altered in CD4⁺CD25⁺FoxP3⁺ T regulatory lymphocytes in pre-eclampsia. Int J Mol Sci (2012) 0.80
Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity (2014) 0.79
The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy. Am J Reprod Immunol (2012) 0.79
Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease. Arch Med Sci (2012) 0.78
Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes. Folia Histochem Cytobiol (2014) 0.78
The expression of B7-H1 and B7-H4 co-stimulatory molecules on myeloid and plasmacytoid dendritic cells in pre-eclampsia and normal pregnancy. J Reprod Immunol (2013) 0.77
Immunomodulatory effects of IFN-beta and lovastatin on immunophenotype of monocyte-derived dendritic cells in multiple sclerosis. Arch Immunol Ther Exp (Warsz) (2010) 0.77
The immunophenotype of patients with recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol (2002) 0.77
The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia. Folia Histochem Cytobiol (2012) 0.77
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. J Neurol Sci (2013) 0.77
The immunological profile of infertile women after repeated IVF failure (preliminary study). Eur J Obstet Gynecol Reprod Biol (2004) 0.76
Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease. Eur J Haematol (2004) 0.76
The frequency of myeloid and lymphoid dendritic cells in multiple myeloma patients is inversely correlated with disease progression. Postepy Hig Med Dosw (Online) (2013) 0.76
Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages. Oncol Rep (2008) 0.75
Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors. ScientificWorldJournal (2012) 0.75
Immunomodulatory effects of cyclophosphamide on the differentiation of Th17 cells. Immunotherapy (2011) 0.75
Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance. Eur Arch Otorhinolaryngol (2013) 0.75
SCID mice model in vivo evaluation of autologous and allogeneic dendritic cells activity on B-cell chronic lymphocytic leukemia. Folia Histochem Cytobiol (2009) 0.75
[The assessment of selected molecules belonging to B7 family on the mature dendritic cells in laryngeal cancer patients]. Otolaryngol Pol (2012) 0.75
[Co-payment for public health care services--public opinion survey]. Przegl Epidemiol (2011) 0.75
Expression of CD200 and CD200R regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer. Folia Histochem Cytobiol (2013) 0.75
Intracellular cytokine expression by T cells differs in ZAP-70-positive and ZAP-70-negative chronic lymphocytic leukaemia patients. Acta Haematol (2007) 0.75
Dendritic cells based immunotherapy of patient with chondrosarcoma--case report. Folia Histochem Cytobiol (2008) 0.75
Expression of galectin-3 in nephrotic syndrome glomerulopaties in children. Folia Histochem Cytobiol (2009) 0.75
Dendritic cell subsets in neoplastic tissue and peripheral blood of laryngeal cancer patients: relation with grade and stage of the disease. Oncol Rep (2012) 0.75
The expressions of co-stimulatory molecules are altered on putative antigen-presenting cells in cord blood. Am J Reprod Immunol (2012) 0.75